Acadian Asset Management LLC Rx Sight, Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$50.42 - $64.29 $500,166 - $637,756	-9,920 Reduced 80.25%	2,441 $146,000
Q1 2024 May 10, 2024	SELL	$35.51 - $57.92 $769,572 - $1.26 Million	-21,672 Reduced 63.68%	12,361 $637,000
Q4 2023 Feb 13, 2024	SELL	$20.91 - $40.9 $2.71 Million - $5.3 Million	-129,628 Reduced 79.21%	34,033 $1.37 Million
Q3 2023 Nov 13, 2023	SELL	$27.05 - $33.37 $88,751 - $109,486	-3,281 Reduced 1.97%	163,661 $4.56 Million
Q2 2023 Aug 07, 2023	BUY	$16.37 - $28.9 $2.5 Million - $4.41 Million	152,702 Added 1072.35%	166,942 $4.81 Million
Q1 2023 May 11, 2023	BUY	$12.58 - $16.68 $179,139 - $237,523	14,240 New	14,240 $236,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $15.85 $18,027 - $25,534	1,611 New	1,611 $19,000

225

32.3M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.22B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.